This is the main reason why it is a good measure to control glucose levels. Your doctor will really know what drugs to prescribe to alleviate the complications of the disease. If you have not yet contracted the disease, monitoring glucose levels in the blood serves as an effective preventive measure.

Here are some tips on the use of a monitor of blood glucose.

Prepare materials and equipment you need. To check levels of blood glucose, blood must be removed from your system. Therefore, it is necessary to have sterile blood lancets or needles prickling used to make punctures to obtain a small blood samples. You should also launching devices that keep their blood lancets in place. It would also be necessary to monitor blood glucose test strips work and clean and sterile, where would the blood sample.

Prepare the lancing device and monitor blood glucose. Get new lancet and place it in your lancing device. When the lancet is firmly seated properly and carefully, remove the cap of such material. The lancing device truly lets you alter the depth of the needle depending on how the monitor displays blood glucose required. After preparing the lancing device together with The Lancet, his own blood glucose monitoring. Place a single test strip and sterile in its proper place in the device. However, be careful not to contaminate the strip to do significantly affect their readings of blood glucose.

Collect the blood sample. Place the lancing device safely on the surface of the finger. Press the designated button on the device to eject the lancet. This process would easily puncture the finger allowing blood to flow. Gently squeeze the sides of the finger to facilitate the flow of blood.

Check your blood glucose from the blood. Place a drop of blood in the assigned area of ​​the strip. The monitor automatically reads your sample. Wait until it stabilizes and then record their reading of blood glucose. You can also use the built in storage function of memory in the monitor of blood glucose if available.

Today, researchers at Baylor announced that they have developed a sensory method that uses a circuit board small enough so that the device is portable.

To measure glucose levels, users must press a part of your hand or finger on the sensor. The Baylor investigadors daily samples of 31 people during the course of several months and compared these samples to levels measured by a commercially available sensor without a prescription. The researchers found that non-invasive sensor Baylor has the potential to achieve the same and even better accuracy than current commercial sensors, many of which require you to prick the finger to sample blood.

“For diabetics, the daily routine of pricking your finger to check levels of blood sugar can be an annoying and inconvenient task, but now we have a device that could potentially change that.” said Dr. Randall Jean, associate professor of computer and electronic engineering at Baylor. “We have the equipment to the point where it justifies a significant investment. The probability of success is very high.”

The sensor uses electromagnetic waves to measure glucose levels in the body. As the energy passes through the skin sensor and back to the sensor, the glucose level is measured by the energy transfer. Jean said that the microwave frequency range is wide enough to isolate the effect of sugar in the body and minimize the capabilities of other things like body fat and bone, which could alter readings. Jean also said that using electromagnetic waves is relatively safe because they do not ionize the molecules of the body as do X-rays.

Jean, who is pre-diabetic, has the patent for the general measurement method called pulse dispersion spectrometry ultra-broadband, and Baylor has applied for a provisional patent in regard to non-invasive monitoring of glucose. Researchers at Baylor now hope to conduct more tests on a larger diabetic population. The current commercial sensors measure the levels of glucose in the range of 20 to 600 milligrams per deciliter, while Baylor prototype sensor has been shown to have a range of 60 to 185 milligrams per deciliter, but Jean said the fact that the sensor has good resolution and accuracy over the limited range demonstrates that the technology can work.

This device would still be in the process of creation, a project that not only has the support of the European Community but also with 7.1 million directly financed by the Community institution.

As anticipated, the basis of DIAdvisor be a small wireless sensors, chip surrounded by a low Sicily, to be pasted into the body of patients and allow more data record: in addition to blood glucose, may also determine the body temperature, blood pressure and oxygen levels.

The same system will then transmit the data to the portable mobile device, which looks like a PDA or PDA.

But also we obtained this information, the device also will allow the patient to go beyond your control and up, for example, information about food that is consumed each day.

According to their own architects have emphasized, the most innovative of this device is to let you know how much insulin is needed: Keith Errey, co-founder of the project and president of Toumaz (manufacturer), highlighted the new opportunities offered to patients who so far have no ways to predict the levels of glucose and insulin they need.

It is worth mentioning, finally, that for the go live DIAdvisor still have to wait. According to estimates, within two years could just start clinical trials in real time with volunteers.

By developing the technology of ultrasound, microwave, laser and infrared light has succeeded in developing a wide range of medical devices that act through electromagnetic waves, sonic or physical. Most important is that these devices are available to any user, and you can get a good home oximeter for a small investment of 100 or 200, although some houses have as Quirumed cheaper models by just over 60 euros plus shipping shipment. In hospitals are classified as having a fixed oximeter plethysmographic curve but for private use or educational enough portable pulse oximeter, hand or finger. Nonin is one of the brands that specialize in pulse, you indicate both the oxygen values as the number of heartbeats per minute.

The normal values of oxygen in blood vary between 95% and 97% SaO2 so easily detected irregularities to be decreases below 95% saturation of O2. Go2 Nonin finger pulse oximeter is cheaper brand, you can buy for $ 99 in a few days pmedicalonline.net and start making the first tests with your own finger. It is designed to be used with fingers of size from millimeters to a centimeter and has 2 year warranty. Among the additions, plus a charger Go2 also have some support for adequate transportation, avoid losses and protect against falls, such as a bag, a briefcase and a simple string. There are several other notebook models Nonin 9500 Onyx from $ 200, and handheld pulse oximeters from $ 400 to $ 600 as the Nonin 2500 PalmSAT.

The main functions of this is patient care and monitoring the level of oxygen in cases of asthma there may be respiratory distress, cyanosis, control of oxygen therapy and the assessment of exercise tolerance. So that according to these functions can perform tests to see how exercise or changes in breathing may alter the level of oxygen in blood. You can also perform other experiences related to research projects specific to the Baccalaureate, to correlate the age with the amount of oxygen in the blood, or measure differences in this value between men and women.

In clinical practice are complementary to the gases, and are widely used in pediatrics to be the least invasive and most friendly to children. So a little ingenuity can be placed permanently if necessary, and notify you of any decrease in blood oxygen saturation. The main disadvantage of these devices is that regard, a gas analysis provides less information: do not measure the concentration of carbon dioxide, or the blood pH, and also for oxygen values are accurate only above 80-90%, so that are not useful for certain pathologies. As advantages we should mention its use simple and fast, in addition to its noninvasive application already discussed earlier.

With these data, patients may tune in the administration of doses, avoiding physiological complications arising from an excess of insulin. In four years it is expected that the technology is available on the market. Scientists say it is very necessary because diabetes is increasingly present in our society as a result of lifestyle we lead. For Yaiza Martínez.

Diabetics can reduce the amount of insulin that administrate with the help of a new portable and wireless device designed to predict blood glucose levels.

This device, known as “DIAdvisor ™” will be developed by the company Toumaz Technology, specializes in manufacturing wireless devices and low power consumption to control the body. The project falls under the Seventh Framework Program of the European Community, which has earmarked 7.1 million euros.

The purpose of development of this device is to improve the lives of millions of diabetes patients, with an art tool for personalized prediction of blood glucose levels, reports Toumaz Technology in a statement.

The tool will be created thanks to a partnership of 13 doctors and several industry partners and academics. The work will be coordinated by Novo Nordisk company specializing in the care of this disease.

What is

DIAdvisor technology (Personal Glucose Predictive Diabetes Advisor) will be based on a wireless control technology of the body, existing and belonging to the company Toumaz Technology Sensium call.

Sensors consist of small, wireless and discreet, surrounded by a silicium chip low-power, which will stick to the body of the sick to log certain data, such as body temperature, blood pressure, blood glucose levels or oxygen, among other parameters.

According to The Engineer magazine reported online, the system transmits this data to a portable mobile device like a PDA or PDA. By hand, it may also introduce any other information you want, like food that has consumed the patient.

All these data will be analyzed later by an advanced algorithm to determine glucose levels in the patient’s blood at any particular time. In this way, patients will know in a matter of minutes, the amount of insulin will be administered at the next dose.

Breakthrough
According to Keith Errey, co-founder and president of Project Toumaz, current techniques for managing diabetes does not offer the ability to predict blood glucose levels in the short term. This means that patients should almost assume the amount of insulin they need to recover the stable levels of blood glucose.

Scientists hope, moreover, that this technology serves to avoid the risk of blackouts suffered by diabetics when their blood sugar levels drop dramatically. Many of the sick, in fact, prefer to consume higher doses of insulin than necessary to avoid the crisis, but the excess insulin also has its risks, including possible damage to the eyes, heart or liver.

But before he can see the light DIAdvisor are still important steps to take, how to define the combination of vital signs that provide the best information to determine the blood glucose level. For this, scientists will have a team of volunteers with diabetes to help generate the physiological models and prediction algorithms.

Within two years, will begin clinical trials in which they will operate these algorithms in real time and test the prediction models. If everything runs according to plan for the scientists, the technology will be available in the market within four years.

Technology increasingly necessary
According to published Toumaz, the massive increase in the incidence of diabetes is now a major global health challenges. This increase is due to demographic trends clear, as the epidemic of obesity, aging, or the spread of sedentary lifestyles.

All these factors have caused a massive spread of diabetes, especially type 2. In the case of type 1 diabetes, the pancreas does not produce insulin, but in the pancreas of type 2 if that makes it, but the body assimilates as it should.

Consequently, the pancreas produces more insulin to get glucose into cells, and just exhausted due to excessive strain. In addition, blood sugar levels get too high.

In the European Union, the average prevalence of this disease is 7.5% but is expected to increase to 16% in 2025. Scientists hope that, with DIAdvisor, it can provide a sophisticated treatment of the sick, thus enhancing self-management of disease and reduce the risk of serious complications resulting from poor control of glucose levels in the blood.

Stergiou of Sotiria Hospital of Athens (Greece) and colleagues assessed the automatic device in 73 people: 27 with atrial fibrillation, 23 with arrhythmia other than atrial fibrillation and 23 reference persons in sinus rhythm.

Overall, rose to 217 blood pressure measurements, all with simultaneous ECG monitoring.

The authors note that when the diagnosis of atrial fibrillation was based in a single measurement, the sensitivity of the algorithm was 93% and specificity of 89%.

Under optimal circumstances (three measurements with at least two to diagnose atrial fibrillation) the sensitivity was 100% and specificity of 89%, indicating a “near perfect match” with the electrocardiograph diagnosis.

Under these optimal circumstances (diagnosis based on two measurements at least three positive) diagnosis of atrial fibrillation was incorrect in five people.

In all these cases, patients had arrhythmia other than atrial fibrillation in the three measurements.

Dr. Stergiou told Reuters Health that long-term self-monitoring of hypertensive patients using a device equipped with an atrial fibrillation detector would allow an earlier diagnosis without additional screening costs.

He added that the “implementation of this technology should be evaluated in other devices for measuring blood pressure and for ambulatory blood pressure monitoring 24-hour blood pressure (especially in patients with intermittent atrial fibrillation), which could also contribute to Early detection of undiagnosed atrial fibrillation and therefore the prevention of stroke. ”

“Additional research is needed on the accuracy of electronic blood pressure monitors in patients with atrial fibrillation, aimed at improving the treatment of hypertension in these patients.”

In a study of 250 Danish adults stricken by a heart attack, Canadian researchers used a tensiometer to intermittently block the blood flow to an arm, an intervention that is started when the patient is transported to hospital by ambulance.

This intervention was developed by the Sick Kids Hospital in Toronto. It greatly limit the damage to heart muscle when a heart artery is blocked.

The sphygmomanometer is inflated for five minutes, then deflated for five minutes, the sequence is repeated four times. The operation lasts between 35 and 40 minutes.

Once at the hospital, the patient receives a typical treatment for a heart attack, including an angioplasty in which an inflatable balloon is used to open an artery blocked or obstructed.

The study, to be published Friday in the prestigious British medical journal The Lancet, says that patients who took the blood pressure response with the sustained 30 percent less damage to heart muscle compared to those who have not received this treatment.

The damage was even reduced by 50 per cent among patients who suffered heart attacks the most devastating.

A leading researcher, Dr. Andrew Redington of Sick Kids, said that the idea behind this technique has been circulating for about 25 years.

When tissues are deprived of blood and oxygen intermittently, he said, it seems to prepare for a more prolonged interruption and a protective substance began to circulate in the body. And as the substance spreads throughout the body, it protects all the organs including the heart.

If Dr. Redington was encouraged by these results, it warns that further studies should be conducted even before the intervention becomes common practice.

His team is developing a particular automated blood pressure monitor that would make intervention easier and more efficient for staff health.

The system check-ups Mobile Tempus IC is able to tell the crew instructions on its use through its color screen.

The Tempus IC is able to perform basic medical tests such as blood pressure, pulse and an electrocardiogram.

This information will be forwarded to “a medical team consisting of experts in medical assistance in flight”.

This system check-up includes merme a camera so that the cabin crew can send pictures of a patient.

According to Captain Richard Hill, who works for Etihad, the system will quickly assess the health of a patient in a medical emergency.

“This will enable us to ensure that a passenger receives treatment appropriate to the aircraft landing in case of diversion or landing safely ‘ex, that he.

Tempus The system was designed and built by the English company and RTD will be installed on the Airbus A340 and Boeing 999 to the company before being deployed on the entire fleet of Etihad.

Thus the blood pressure but can be successful and will be sent to exact values, certain guidelines are met. Is always measured on the inside of the wrist. The cuff is applied to the artery. To obtain accurate measurement data, it is necessary to first consider the wrist at heart level to. The short time that requires a blood pressure measurement should be spent in silence. That is, it is a relaxed position – for example, sitting or lying position to take -. Nor can it be said, to avoid incorrect measurements during the measurement. Fairs give instructions on how to correct the manuals of the wrist blood pressure monitors that are located in the packaging of products.

The calculated pressure is shown on a display. There appear several levels – firstly, the systolic, upper blood pressure and secondly, the diastolic, the lower pressure. In addition, modern digital blood pressure monitors also indicate the pulse rate.